amotosalen has been researched along with Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Compernolle, V; Devloo, R; Feys, HB; Van Aelst, B; Vandekerckhove, P; Vanhoorelbeke, K | 1 |
| Conlan, MG; Corash, L; Lin, JS; Lopez-Plaza, I; McCullough, J; Slichter, SJ; Snyder, E; Strauss, RG | 1 |
1 trial(s) available for amotosalen and Thrombosis
| Article | Year |
|---|---|
Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
Topics: Adult; Bacteria; Bacterial Infections; Blood Banking; Blood Banks; Cause of Death; Female; Furocoumarins; Hemorrhage; Humans; Incidence; Male; Middle Aged; Platelet Transfusion; Plateletpheresis; Safety; Skin Diseases; Thrombocytopenia; Thrombosis; Ultraviolet Rays | 2005 |
1 other study(ies) available for amotosalen and Thrombosis
| Article | Year |
|---|---|
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro.
Topics: Blood Platelets; Collagen; Furocoumarins; Humans; Integrin beta3; Photosensitizing Agents; Platelet Activation; Platelet Aggregation; Riboflavin; Thrombosis; Ultraviolet Rays; von Willebrand Factor | 2015 |